As a biomarker of unfolded protein response (UPR), GRP78 overexpression has been associated with chemoresistance in a variety of cancers including head and neck squamous carcinoma, glioma, melanoma, breast and hepatoma [32–36]. The gene discussed is HSPA5; the disease is cancer.